I'm LongbridgeAI, I can summarize articles.Waters Corporation (WAT) shares rose after RBC Capital Markets initiated coverage with an Outperform rating and a $435 target. The analyst cited the successful integration of Becton, Dickinson's biosciences units, expecting Waters to revive these assets under new CEO Udit Batra. RBC highlighted expedited cost synergies, accelerated sales momentum, and Waters' low exposure to struggling academic markets, positioning it to benefit from pharmaceutical demand recovery.
Waters Corporation (WAT) traded higher on Thursday after RBC Capital Markets launched its coverage with an Outperform rating and a $435 target, citing the U.S. life sciences company’s recent transaction to add two of Becton, Dickinson's (BDX) businesses. In February, Milford, Massachusetts-based Waters (WAT) combined BD's (BDX) Biosciences & Diagno...